Hochschulschrift(en), die von Zahler, Stefan begutachtet wurde(n)

Köhler, Bianca (2024): MicroRNA-200c as chemosensitizer and metastasis suppressor: novel insights from in vitro and in vivo investigations. Dissertation, LMU München: Fakultät für Chemie und Pharmazie

Jauch, Adrian Tibor (2023): Neocarzilins – natural compounds with diverse molecular targets and biological effects. Dissertation, LMU München: Fakultät für Chemie und Pharmazie

Hu, Yudong (2023): Identification of the novel antitumor targets of Lagunamide A and Neocarzilin A. Dissertation, LMU München: Fakultät für Chemie und Pharmazie

Isert, Lorenz (2023): In-vitro modeling and nanoparticulate targeting of EMT in breast cancer. Dissertation, LMU München: Fakultät für Chemie und Pharmazie

Lengauer, Florian (2023): Targeting glutamine metabolism and mitochondria via natural compounds in cancer: novel therapeutic strategies. Dissertation, LMU München: Fakultät für Chemie und Pharmazie

Geißlinger, Franz Florian Sebastian (2023): Targeting endolysosomal cation channels to modulate cancer cell death. Dissertation, LMU München: Fakultät für Chemie und Pharmazie

Göl Öztürk, Şurhan (2022): Transferrin receptor targeted gene delivery. Dissertation, LMU München: Fakultät für Chemie und Pharmazie

Wang, Pengyu (2022): Complementary target identification approaches for the identification of protein binding partners of phyllobilins, a family of abundant natural products. Dissertation, LMU München: Fakultät für Chemie und Pharmazie

Siow, Wei Xiong (2022): Functional characterization of transient receptor potential mucolipin-1 channels – potential target for cancer therapy. Dissertation, LMU München: Fakultät für Chemie und Pharmazie

Vepřek, Nynke Anna (2021): The photopharmacology of actin and cytoskeletal regulators and de novo design of SARS-CoV-2 main protease inhibitors. Dissertation, LMU München: Fakultät für Chemie und Pharmazie

Karg, Cornelia (2021): The potential of phyllobilins, the breakdown products of the green plant pigment chlorophyll, as bioactive natural compounds. Dissertation, LMU München: Fakultät für Chemie und Pharmazie

Geiger, Florian (2021): Directed invasion and migratory modes of cancer cells in structured 3D collagen matrices. Dissertation, LMU München: Fakultät für Chemie und Pharmazie

Sommer, Ann-Katrin (2021): Development of chemoresistance and formation of metastases: New aspects of two major obstacles in breast cancer treatment. Dissertation, LMU München: Fakultät für Chemie und Pharmazie

Kraus, Yvonne (2021): Photoswitchable and non-photoswitchable tubulin inhibitors for applications in cell biology. Dissertation, LMU München: Fakultät für Chemie und Pharmazie

Illes, Bernhard (2020): Nanotools for cancer research and therapy. Dissertation, LMU München: Fakultät für Chemie und Pharmazie

Ljepoja, Bojan (2019): Novel roles of miRNA-27a and miRNA-200c in breast cancer treatment and metastasis. Dissertation, LMU München: Fakultät für Chemie und Pharmazie

Moser, Christina (2017): Novel treatment strategies and mechanisms of actin binding compounds in cancer therapy. Dissertation, LMU München: Fakultät für Chemie und Pharmazie

Röder, Ruth (2017): Bioresponsive nanocarriers for targeted intracellular delivery of proteins and peptides. Dissertation, LMU München: Fakultät für Chemie und Pharmazie

Müller, Katharina (2016): Nanocarriers based on sequence-defined oligomers for tumor-targeted siRNA and miRNA delivery. Dissertation, LMU München: Fakultät für Chemie und Pharmazie

Merk, Henriette (2016): Inhibition of the V-ATPase - A novel strategy to prevent epithelial-mesenchymal transition and cancer stem cell formation. Dissertation, LMU München: Fakultät für Chemie und Pharmazie

Stoiber, Katharina (2016): The myxobacterial acetyl-CoA carboxylase inhibitor Soraphen A as a novel anti-metastatic and anti-proliferative agent. Dissertation, LMU München: Fakultät für Chemie und Pharmazie

Hermawan, Adam (2015): Molecular evolution assays reveal novel targets and mechanisms of drug resistance. Dissertation, LMU München: Fakultät für Chemie und Pharmazie

Marfels, Christian (2015): Characterization of in vivo chemoresistant human hepatocellular carcinoma cells with transendothelial differentiation capacities. Dissertation, LMU München: Fakultät für Chemie und Pharmazie

Zhang, Siwei (2014): Evaluation of the natural compound Archazolid and its target V-ATPase for treatment of T-cell acute lymphoblastic leukemia & Evaluation of Cdk5 as target for breast cancer treatment. Dissertation, LMU München: Fakultät für Chemie und Pharmazie

Ehrlich, Sandra Monika (2014): Targeting cyclin dependent kinase 5 in hepatocellular carcinoma: a novel therapeutic approach. Dissertation, LMU München: Fakultät für Chemie und Pharmazie

Kos, Petra (2014): Defined nanocarriers for improved and targeted gene delivery. Dissertation, LMU München: Fakultät für Chemie und Pharmazie

Förster, Florian (2014): Targeting the actin cytoskeleton with natural compounds: elucidating the underlying mechanism of apoptosis induction. Dissertation, LMU München: Fakultät für Chemie und Pharmazie

Schempp, Christina Maria (2014): The V-ATPase inhibitor archazolid: Impact on anoikis resistance in metastatic cancer cells. Dissertation, LMU München: Fakultät für Chemie und Pharmazie

Kopp, Florian (2013): Novel insights into the role of microRNAs in chemoresistance, tumor progression and cancer therapy. Dissertation, LMU München: Fakultät für Chemie und Pharmazie

Wiedmann, Romina Madeleine (2011): Anticancer effects of the V-ATPase inhibitor Archazolid B. Dissertation, LMU München: Fakultät für Chemie und Pharmazie

Mayer, Bettina (2010): IAP antagonism as a novel approach to target endothelial activation. Dissertation, LMU München: Fakultät für Chemie und Pharmazie

Hartkorn, Andreas (2008): Different approaches to influence the ischemia/reperfusion injury of the liver. Dissertation, LMU München: Fakultät für Chemie und Pharmazie